Navigation Links
Injectable Drug Delivery to 2016
Date:9/13/2012

NEW YORK, Sept. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Injectable Drug Delivery to 2016

http://www.reportlinker.com/p0967090/-Injectable-Drug-Delivery-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights

  • Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication
  • Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues
  • Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies
  • Forecasts Injectable drug product demand by indication and therapy to 2016• Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations Executive Summary

Injectable Drug Delivery Market Dynamics

The Injectable Drug Ecosystem Injectable Drug Demand Drivers Drug Development Factors Market Factors Technology Factors Competitive Landscape Autoinjectors Needle-free Injectors Pen Injectors Prefilled Syringes Safety Syringes Injectable Drug Demand Drivers Diseases and Indications Patient Demographics Developing Economies Risks and Opportunities

Injectable Drug Device Selection Criteria

Stability and Material Selection Issues Single vs Multi-Dose Devices Lyophilized Drugs/Reconstitution Syringe Safety/Sharps Protection Needle Configuration Strategies Disposable Drug Cartridges Human Engineering/Ergonomics Branding/Private Labeling

Injectable Drug Delivery – Device Segments

Autoinjectors Autoinjector-specific Selection Factors Part Counts and Device Cost Safety Features Needle Shielding Needle Insertion Depth Failsafe Activation Dose Inspection/Injection Confirmation Autoinjector Device Categories Reusable Autoinjectors Disposable Autoinjectors Product Specific Autoinjectors Drugs and Therapeutic Segments

Needle-free Injectors

Device Categories

End User/Practitioner/Mass Immunization Injectors

Prefilled Disposable Models

Refillable Cartridge Designs

Needle-free Injector-specific Selection Factors

Energy Source

Injection Site Selection

Pen Injectors Pen Injector Device Categories Standardized Pen Platforms Custom Pen Designs Reusable Pens Prefilled Pen Cartridges Disposable Pens Dual Chamber Pens Branded Drug/Pen Injector Product by Therapeutic Segment

Prefilled Syringes

Prefilled Syringe Device Categories

Glass Prefilled Syringes

Prefillable Glass Syringe Manufacturers and Branded Devices

Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment

Plastic Prefilled Syringes

Branded Prefillable Plastic Syringes

Drugs and Therapeutic Segments

Prefillable Safety Syringes

Prefilled Syringe-specific Selection Factors

PFS Manufacturing Factors

Fill-and-Finish Operations

Safety Syringes Safety Syringe Device Categories Prefillable Integrated Safety Syringes Non-Prefillable Integrated Safety Syringes Retractable Needle Manually Retractable Automatic Retractable Sliding Sheath

Injectable Drug Delivery – Therapeutic Segment Analysis & Forecasts

Anaphylaxis Anticoagulants Antivirals Autoimmune Diseases Emergency Medicine Hematopoietics Hormone Replacement Metabolic Diseases Neurology Reproductive Health Vaccines

Injectable Drug Therapeutics - Market Factors

Regulatory Factors and Issues FDA Regulations Regulating Combination Products Sharps Legislations Growth and Diversity of Safety Syringes Sharps Disposal Clinical Trial Factors Managed Care and Healthcare Economics

Company Profiles

To order this report: Drug_Delivery_Technology Industry: Injectable Drug Delivery to 2016

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Summer Is the Best Time for Injectable Treatments
2. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
3. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
4. Philips continues to improve access to treatment for common cause of death in the U.S. with the delivery of its one-millionth AED
5. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
6. GeNO LLC Receives Four Additional Patents for Inhaled Nitric Oxide Delivery
7. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
8. GeNO LLC Receives FDA Marketing Clearance For Its Inhaled Nitric Oxide Drug Delivery Device
9. AHM Announces New SVP Product Delivery
10. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
11. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, a ... medical technology for non-invasive surgery, announced today CE ... for treatment of uterine fibroids throughout the European ... received approval from the US Food and Drug ... Mirabilis System in the United States.  The Mirabilis ...
(Date:3/24/2017)... GENEVA , March 24, 2017 ... efforts to develop sutezolid as effective response to infectious ... TB Alliance and the Medicines Patent Pool (MPP) announced ... an antibiotic drug candidate which demonstrated encouraging results in ... sutezolid in combination with other TB drugs and follows ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... The Global Cryostat Market ... the next decade to reach approximately $3.5 billion by 2025. ... all the given segments on global as well as regional levels ...
Breaking Medicine Technology:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... Viewers who ... variety of critical historical facts, cultural practices, goods, services, and societal issues tend to ... will look into the popular practice of utilizing running events for causes around the ...
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in ... and leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance ... is designed to teach how to maximize their sales efforts, as well as ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... with God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion ... to Walk with God #TruthwithGrace” is the creation of published author Lea Michelle ...
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/24/2017)... ... March 24, 2017 , ... “The Adventures of Joey, The ... silly dog who lives his life to the fullest, as God intended. “The Adventures ... Patti Holmgren, a mother and grandmother pursuing her passion for writing, especially about truth ...
Breaking Medicine News(10 mins):